Addiction suppression: Difference between revisions
>Oskykins No edit summary |
>Oskykins No edit summary |
||
Line 1: | Line 1: | ||
<onlyinclude>'''Addiction suppression''' can be described as the experience of a total or partial removal of a psychological addiction to a specific substance and the cravings associated with it. This can occur as an effect which lasts long after the compound wears off or it can last only while it is still active. Addiction suppression is a rare component and is most commonly associated with [[psychedelic]]s<ref>Psychedelics: entering a new age of addiction therapy | http://www.pharmaceutical-journal.com/news-and-analysis/features/psychedelics-entering-a-new-age-of-addiction-therapy/20066899.article#fn_link_1</ref>, [[psilocin]]<ref>Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286320/</ref>, [[LSD]]<ref>Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/22406913</ref>, [[ibogaine]]<ref>Mind-altering drug could offer life free of heroin (New Scientist) | https://www.newscientist.com/article/mg21929313-900-mind-altering-drug-could-offer-life-free-of-heroin/</ref> and [[N-acetylcysteine]] (NAC).<ref>Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/16000629</ref> | <onlyinclude>'''Addiction suppression''' can be described as the experience of a total or partial removal of a psychological addiction to a specific substance and the cravings associated with it. This can occur as an effect which lasts long after the compound wears off or it can last only while it is still active. Addiction suppression is a rare component and is most commonly associated with [[psychedelic]]s<ref>Psychedelics: entering a new age of addiction therapy | http://www.pharmaceutical-journal.com/news-and-analysis/features/psychedelics-entering-a-new-age-of-addiction-therapy/20066899.article#fn_link_1</ref>, [[psilocin]]<ref>Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286320/</ref>, [[LSD]]<ref>Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/22406913</ref>, [[ibogaine]]<ref>Mind-altering drug could offer life free of heroin (New Scientist) | https://www.newscientist.com/article/mg21929313-900-mind-altering-drug-could-offer-life-free-of-heroin/</ref> and [[N-acetylcysteine]] (NAC).<ref>Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/16000629</ref> | ||